Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual-release Hydrocortisone vs Conventional Glucocorticoids in Adrenal Insufficiency
NCT06260462Phase 3Completed
- Sponsor
- University of Palermo
- Start
- Jan 2012
- Primary completion
- Sep 2022
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of hydrocortisone in adrenal insufficiency (AI) (2 arms), sponsored by University of Palermo. Primary endpoint: Change of body weight at 10 years. Started Jan 2012; status: completed.
02
Drugs
hydrocortisone
03
Conditions
adrenal insufficiency (AI)
Beyond the preview
Go deeper on NCT06260462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06260462.